I was pretty unhappy with the results and ready to blame it on the "faulty" trial design, but then Nader reminded us that the protocol was written in April 2020 and the situation, knowledge about the disease and SOC was very different then. You can read it for yourself:

https://clinicaltrials.gov/ct2/show/NCT043472...amp;rank=1

It's not surprising that all the changes caused problems that would have been hard to foresee 11 months ago. Ganesha